PLA2G4A/cPLA2-mediated Lysosomal Membrane Damage Leads to Inhibition of Autophagy and Neurodegeneration After Brain Trauma

Overview

Journal Autophagy

Specialty Cell Biology

Date 2019 Jun 27

PMID 31238788

Citations 63

Authors

Chinmoy Sarkar

Jace W Jones

Nivedita Hegdekar

Julia A Thayer

Alok Kumar

Alan I Faden

Maureen A Kane

Marta M Lipinski

Affiliations

Soon will be listed here.

Abstract

Lysosomal membrane permeabilization (LMP) is observed under many pathological conditions, leading to cellular dysfunction and death. However, the mechanisms by which lysosomal membranes become leaky are not clear. Our data demonstrate that LMP occurs in neurons following controlled cortical impact induced (CCI) traumatic brain injury (TBI) in mice, leading to impaired macroautophagy (autophagy) and neuronal cell death. Comparison of LC-MS/MS lysosomal membrane lipid profiles from TBI and sham animals suggested a role for PLA2G4A/cPLA2 (phospholipase A2, group IVA [cytosolic, calcium-dependent]) in TBI-induced LMP. Activation of PLA2G4A caused LMP and inhibition of autophagy flux in cell lines and primary neurons. pharmacological inhibition of PLA2G4A attenuated TBI-induced LMP, as well as subsequent impairment of autophagy and neuronal loss, and was associated with improved neurological outcomes. Inhibition of PLA2G4A limited amyloid-β-induced LMP and inhibition of autophagy. Together, our data indicate that PLA2G4A -mediated lysosomal membrane damage is involved in neuronal cell death following CCI-induced TBI and potentially in other neurodegenerative disorders.: AACOCF, arachidonyl trifluoromethyl ketone; ACTB/β-actin, actin, beta; AD, Alzheimer disease; ATG5, autophagy related 5; ATG7, autophagy related 7; ATG12, autophagy related 12; BECN1, beclin 1, autophagy related; C1P, ceramide-1-phosphate; CCI, controlled cortical impact; CTSD, cathepsin D; CTSL, cathepsin L; GFP, green fluorescent protein; IF, immunofluorescence; LAMP1, lysosomal-associated membrane protein 1; LAMP2, lysosomal-associated membrane protein 2; LC-MS/MS, liquid chromatography-tandem mass spectrometry; LMP, Lysosomal membrane permeabilization; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; MAP1LC3/LC3, microtuble-associated protein 1 light chain 3; NAGLU, alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB); PC, diacyl glycerophosphatidylcholine; PE, diacyl glycerophosphatidylethanolamine; PE-O, plasmanyl glycerophosphatidylethanolamine; PE-P, plasmenyl glycerophosphatidylethanolamine; PLA2G4A/cPLA2, phospholipase A2, group IVA (cytosolic, calcium-dependent); RBFOX3, RNA binding protein, fox-1 homolog (C. elegans) 3; RFP, red fluorescent protein; ROS, reactive oxygen species; SQSTM1, sequestosome 1; TUBA1/α-tubulin, tubulin, alpha; TBI, traumatic brain injury; TFEB, transcription factor EB; ULK1, unc-51 like kinase 1.

Citing Articles

CENPF interaction with PLA2G4A promotes glioma growth by modulating mTORC1 and NF-κB pathways.

Li J, Zhang M, Sun Q, Li X, Du F, Cheng Y Cancer Cell Int. 2025; 25(1):73.

PMID: 40025532 PMC: 11871623. DOI: 10.1186/s12935-025-03700-6.

Research progress of cPLA2 in cardiovascular diseases (Review).

Lin W, Wang S, Liu R, Zhang D, Zhang J, Qi X Mol Med Rep. 2025; 31(4).

PMID: 39981923 PMC: 11868774. DOI: 10.3892/mmr.2025.13468.

OSBP Participates in Neural Damage Repair by Regulating Lysosome Transport Under Oxidative Stress.

Fei M, Luo S, Gao C, Huang X, Wang L, Jin T Mol Neurobiol. 2025; .

PMID: 39915357 DOI: 10.1007/s12035-025-04698-8.

YTHDF3-mediated FLCN/cPLA2 axis improves cardiac fibrosis via suppressing lysosomal function.

Zhang Y, Diao H, Leng M, Wu Y, Huang B, Li X Acta Pharmacol Sin. 2025; .

PMID: 39806064 DOI: 10.1038/s41401-024-01425-2.

Cytosolic phospholipase A2 in infiltrating monocyte derived macrophages does not impair recovery after spinal cord injury in female mice.

Glaser E, Kopper T, Bailey W, Kashif H, Kumari R, Stewart A Sci Rep. 2025; 15(1):1.

PMID: 39747330 PMC: 11696740. DOI: 10.1038/s41598-024-84936-6.

References

Corrotte M, Castro-Gomes T, Koushik A, Andrews N . Approaches for plasma membrane wounding and assessment of lysosome-mediated repair responses. Methods Cell Biol. 2015; 126:139-58. PMC: 4739812. DOI: 10.1016/bs.mcb.2014.11.009. View

DE DUVE C . The peroxisome: a new cytoplasmic organelle. Proc R Soc Lond B Biol Sci. 1969; 173(1030):71-83. View

Leslie C . Cytosolic phospholipase A₂: physiological function and role in disease. J Lipid Res. 2015; 56(8):1386-402. PMC: 4513982. DOI: 10.1194/jlr.R057588. View

Luzio J, Pryor P, Bright N . Lysosomes: fusion and function. Nat Rev Mol Cell Biol. 2007; 8(8):622-32. DOI: 10.1038/nrm2217. View

Phillis J, ORegan M . A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res Brain Res Rev. 2004; 44(1):13-47. DOI: 10.1016/j.brainresrev.2003.10.002. View

Gomez-Sintes R, Ledesma M, Boya P . Lysosomal cell death mechanisms in aging. Ageing Res Rev. 2016; 32:150-168. DOI: 10.1016/j.arr.2016.02.009. View

Monteiro-Cardoso V, Oliveira M, Melo T, Domingues M, Moreira P, Ferreiro E . Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease. J Alzheimers Dis. 2014; 43(4):1375-92. DOI: 10.3233/JAD-141002. View

Mosior M, Six D, Dennis E . Group IV cytosolic phospholipase A2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity. J Biol Chem. 1998; 273(4):2184-91. DOI: 10.1074/jbc.273.4.2184. View

Kilpatrick B, Eden E, Hockey L, Futter C, Patel S . Methods for monitoring lysosomal morphology. Methods Cell Biol. 2015; 126:1-19. DOI: 10.1016/bs.mcb.2014.10.018. View

10.

Zhang Z, Lee Y, Kim S, Choi M, Tsai P, Saha A . Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration. Hum Mol Genet. 2007; 16(7):837-47. DOI: 10.1093/hmg/ddm029. View

11.

Zhu X, Park J, Golinski J, Qiu J, Khuman J, Lee C . Role of Akt and mammalian target of rapamycin in functional outcome after concussive brain injury in mice. J Cereb Blood Flow Metab. 2014; 34(9):1531-9. PMC: 4158669. DOI: 10.1038/jcbfm.2014.113. View

12.

Faden A . Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol. 2002; 15(6):707-12. DOI: 10.1097/01.wco.0000044767.39452.bf. View

13.

Aits S, Jaattela M . Lysosomal cell death at a glance. J Cell Sci. 2013; 126(Pt 9):1905-12. DOI: 10.1242/jcs.091181. View

14.

Matyash V, Liebisch G, Kurzchalia T, Shevchenko A, Schwudke D . Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res. 2008; 49(5):1137-46. PMC: 2311442. DOI: 10.1194/jlr.D700041-JLR200. View

15.

Rodriguez-Muela N, Hernandez-Pinto A, Serrano-Puebla A, Garcia-Ledo L, Latorre S, de la Rosa E . Lysosomal membrane permeabilization and autophagy blockade contribute to photoreceptor cell death in a mouse model of retinitis pigmentosa. Cell Death Differ. 2014; 22(3):476-87. PMC: 4326579. DOI: 10.1038/cdd.2014.203. View

16.

Pettus B, Bielawska A, Subramanian P, Wijesinghe D, Maceyka M, Leslie C . Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J Biol Chem. 2003; 279(12):11320-6. DOI: 10.1074/jbc.M309262200. View

17.

Farooqui A, Ong W, Horrocks L . Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev. 2006; 58(3):591-620. DOI: 10.1124/pr.58.3.7. View

18.

Street I, Lin H, Laliberte F, Ghomashchi F, Wang Z, Perrier H . Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry. 1993; 32(23):5935-40. DOI: 10.1021/bi00074a003. View

19.

Sarkar C, Zhao Z, Aungst S, Sabirzhanov B, Faden A, Lipinski M . Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy. 2014; 10(12):2208-22. PMC: 4502690. DOI: 10.4161/15548627.2014.981787. View

20.

Sharma S, Ying Z, Gomez-Pinilla F . A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma. Exp Neurol. 2010; 226(1):191-9. PMC: 3225197. DOI: 10.1016/j.expneurol.2010.08.027. View